Insider Trading Alert - Stryker Corporation And 4 Others Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Oct. 15, 2013, 94 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $5.48 to $122,908,412.25.

Highlighted Stocks Traded by Insiders:

Stryker Corporation (SYK) - FREE Research Report

Stryker Ronda E who is Director at Stryker Corporation sold 14,000 shares at $70.04 on Oct. 15, 2013. Following this transaction, the Director owned 11.6 million shares meaning that the stake was reduced by 0.12% with the 14,000 share transaction.

The shares most recently traded at $67.54, down $2.50, or 3.71% since the insider transaction. Historical insider transactions for Stryker Corporation go as follows:

  • 4-Week # shares sold: 2,000
  • 12-Week # shares sold: 2,000
  • 24-Week # shares sold: 28,000

The average volume for Stryker Corporation has been 1.2 million shares per day over the past 30 days. Stryker Corporation has a market cap of $26.8 billion and is part of the health care sector and health services industry. Shares are up 29.2% year to date as of the close of trading on Friday.

Stryker Corporation, a medical technology company, provides reconstructive, medical and surgical, and neurotechnology and spine products for doctors, hospitals, and other healthcare facilities. The stock currently has a dividend yield of 1.5%. The company has a P/E ratio of 23.8. Currently there are 13 analysts that rate Stryker Corporation a buy, 1 analyst rates it a sell, and 12 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on SYK - FREE

TheStreet Quant Ratings rates Stryker Corporation as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, solid stock price performance and expanding profit margins. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full Stryker Corporation Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Mead Johnson Nutrition Company (MJN) - FREE Research Report

Golsby Stephen W who is Director at Mead Johnson Nutrition Company sold 10,000 shares at $75.28 on Oct. 15, 2013. Following this transaction, the Director owned 90,172 shares meaning that the stake was reduced by 9.98% with the 10,000 share transaction.

The shares most recently traded at $75.09, down $0.19, or 0.25% since the insider transaction. Historical insider transactions for Mead Johnson Nutrition Company go as follows:

  • 4-Week # shares bought: 10,000
  • 4-Week # shares sold: 10,000
  • 12-Week # shares bought: 10,000
  • 12-Week # shares sold: 20,525
  • 24-Week # shares bought: 10,000
  • 24-Week # shares sold: 63,035

The average volume for Mead Johnson Nutrition Company has been 2.1 million shares per day over the past 30 days. Mead Johnson Nutrition Company has a market cap of $15.4 billion and is part of the consumer goods sector and food & beverage industry. Shares are up 15.6% year to date as of the close of trading on Friday.

Mead Johnson Nutrition Company manufactures, distributes, and sells infant formulas, children's nutrition, and other nutritional products. The stock currently has a dividend yield of 1.79%. The company has a P/E ratio of 25.6. Currently there are 4 analysts that rate Mead Johnson Nutrition Company a buy, no analysts rate it a sell, and 8 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on MJN - FREE

TheStreet Quant Ratings rates Mead Johnson Nutrition Company as a buy. The company's strengths can be seen in multiple areas, such as its notable return on equity, revenue growth, expanding profit margins and increase in stock price during the past year. We feel these strengths outweigh the fact that the company is trading at a premium valuation based on our review of its current price compared to such things as earnings and book value. Get the full Mead Johnson Nutrition Company Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Hexcel Corporation (HXL) - FREE Research Report

Pensky Wayne C who is Svp, Cfo at Hexcel Corporation sold 15,000 shares at $40.06 on Oct. 15, 2013. Following this transaction, the Svp, Cfo owned 87,608 shares meaning that the stake was reduced by 14.62% with the 15,000 share transaction.

The shares most recently traded at $39.09, down $0.97, or 2.48% since the insider transaction. Historical insider transactions for Hexcel Corporation go as follows:

  • 24-Week # shares sold: 23,000

The average volume for Hexcel Corporation has been 494,100 shares per day over the past 30 days. Hexcel Corporation has a market cap of $3.8 billion and is part of the industrial goods sector and aerospace/defense industry. Shares are up 42.4% year to date as of the close of trading on Friday.

Hexcel Corporation, together with its subsidiaries, engages in the development, manufacture, and marketing of lightweight and high-performance structural materials for use in commercial aerospace, space and defense, and industrial applications. The company has a P/E ratio of 23.3. Currently there are 7 analysts that rate Hexcel Corporation a buy, 1 analyst rates it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on HXL - FREE

TheStreet Quant Ratings rates Hexcel Corporation as a buy. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures, growth in earnings per share, good cash flow from operations and solid stock price performance. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full Hexcel Corporation Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

United Natural Foods (UNFI) - FREE Research Report

Heffernan James P who is Director at United Natural Foods sold 1,064 shares at $67.45 on Oct. 15, 2013. Following this transaction, the Director owned 800 shares meaning that the stake was reduced by 57.08% with the 1,064 share transaction.

The shares most recently traded at $66.18, down $1.27, or 1.92% since the insider transaction. Historical insider transactions for United Natural Foods go as follows:

  • 4-Week # shares sold: 35,131
  • 12-Week # shares sold: 42,156
  • 24-Week # shares sold: 59,571

The average volume for United Natural Foods has been 267,400 shares per day over the past 30 days. United Natural Foods has a market cap of $3.3 billion and is part of the services sector and wholesale industry. Shares are up 25.71% year to date as of the close of trading on Friday.

United Natural Foods, Inc., together with its subsidiaries, distributes and retails natural, organic, and specialty foods, as well as non-food products primarily in the United States and Canada. The company has a P/E ratio of 30.6. Currently there are 5 analysts that rate United Natural Foods a buy, 1 analyst rates it a sell, and 4 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on UNFI - FREE

TheStreet Quant Ratings rates United Natural Foods as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, impressive record of earnings per share growth, compelling growth in net income, largely solid financial position with reasonable debt levels by most measures and increase in stock price during the past year. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full United Natural Foods Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Ascena Retail Group (ASNA) - FREE Research Report

Rayden Michael W who is CEO, Tween Brands, Inc. at Ascena Retail Group sold 44,668 shares at $19.46 on Oct. 15, 2013. Following this transaction, the CEO, Tween Brands, Inc. owned 4,761 shares meaning that the stake was reduced by 90.37% with the 44,668 share transaction.

The shares most recently traded at $20.39, up $0.93, or 4.57% since the insider transaction. Historical insider transactions for Ascena Retail Group go as follows:

  • 4-Week # shares sold: 131,597
  • 12-Week # shares sold: 131,597
  • 24-Week # shares sold: 131,597

The average volume for Ascena Retail Group has been 1.2 million shares per day over the past 30 days. Ascena Retail Group has a market cap of $2.8 billion and is part of the services sector and retail industry. Shares are down 6.23% year to date as of the close of trading on Friday.

Ascena Retail Group, Inc., through its subsidiaries, operates as a specialty retailer of apparel for women, and tween girls and boys. The company operates under the Justice, Lane Bryant, maurices, dressbarn, and Catherines segments. The company has a P/E ratio of 18.2. Currently there are 3 analysts that rate Ascena Retail Group a buy, 1 analyst rates it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on ASNA - FREE

TheStreet Quant Ratings rates Ascena Retail Group as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, increase in net income, good cash flow from operations, expanding profit margins and growth in earnings per share. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. Get the full Ascena Retail Group Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

Data for this article provided by Zacks Investment Research
null

If you liked this article you might like

Stocks Need to Move Lower to Be Able to Move Higher Again: Market Recon

Stocks Need to Move Lower to Be Able to Move Higher Again: Market Recon

11 Stocks Our Experts Love for November

11 Stocks Our Experts Love for November

Remember That Bumps in the Road Are Normal: Market Recon

Remember That Bumps in the Road Are Normal: Market Recon

Smith & Nephew Surges to Record High on Reports of Elliott Stake

Smith & Nephew Surges to Record High on Reports of Elliott Stake

These Stocks Are Ready to Reverse Course

These Stocks Are Ready to Reverse Course